Learn how to identify RSV symptoms in adults, how to know if an RSV infection has become serious, how to avoid RSV, and whether to get an RSV vaccine.

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

ST. PETERSBURG, Fla. — While the respiratory syncytial virus, known as RSV, is often thought of as a childhood issue, experts said many overlook its impact on adults. As a result, the Centers for ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way. On Wednesday, the US Food and Drug Administration ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

Peak season ranges from late December to mid-February every year, the CDC website says. Last year in North Carolina, RSV ...

The shot's efficacy declined slightly compared with the levels of protection after one RSV season, but the new data suggests that the jab generally offers durable protection for adults ages 60 and ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...